Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.

Zhu P, Davis M, Blackwelder AJ, Bachman N, Liu B, Edgerton S, Williams LL, Thor AD, Yang X. Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models. Cancer Prev Res (Phila). 2014 Feb; 7(2):199-210.

View in: PubMed

subject areas

Animals
Cells, Cultured
Female
Gene Expression Regulation, Neoplastic
Genes, erbB-2
Humans
Integrin alpha6
Integrin beta3
Mammary Neoplasms, Experimental
Metformin
Mice
Mice, Transgenic
Neoplastic Stem Cells
Organ Specificity

authors with profiles

Xiaohe Yang

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support